(A[i]) Macaques (n = 9 per group) were vaccinated with monovalent A/Singapore/GP1908/2015 (H1N1) WPV or SV followed by a second dose 28 days later. Blood was collected prior to receiving each dose (day 0 pre-bleed and day 28) and at day 56. (A[ii]) List of antigen and strain information used for multiplex analysis. (B) Cytokine levels in plasma obtained at 0, 6 and 24 hours after the first dose. Dotted lines indicate the manufacturer’s theoretical limit of detection. (C) Hemagglutination inhibition (HI) was measured against A/Singapore/GP1908/2015 (H1N1) and A/Singapore/INFIMH-16-0019/2016 (H3N2). Individual HI antibody titres are expressed as reciprocals of the highest plasma dilutions that showed complete inhibition of agglutination. (D) ...
<p>(<b>A</b>) Three groups of macaques (N = 8) were immunized 4 times (V1 to V4) with SIVmac239 deri...
<p>Virus infection status was determined by PCR for SIV<i>gag</i> proviral DNA and virus isolation (...
We made an H1N1 vaccine candidate from a virus library consisting of 144 ( = 16 HA69 NA) non-pathog...
(A) Macaques (n = 3 per group) were infected with A/Yokohama/91/2007 (H1N1) and 56 days later vaccin...
(A) Volcano plots of 17 humoral immune parameters following either one (SV or WPV) or two doses (SV⇢...
(A) Plasma collected at each time point was assessed for HI against vaccine-matched H1N1, H3N2 and I...
(A) Macaques (n = 8 per group) were vaccinated with quadrivalent WPV or SV formulations. A second do...
(A) Plasma from animals vaccinated with monovalent A/Singapore/GP1908/2015 (H1N1) WPV or SV (day 28)...
Macaques (n = 9 per group) were vaccinated with monovalent A/Singapore/GP1908/2015 (H1N1) WPV or SV ...
<p>Cynomolgus macaques (n = 8) received 3 immunizations with the LT-MA DNA vaccine at 0, 6, and 12 w...
<p>Cynomolgus macaques were subcutaneously immunized twice (in weeks 0 and 2) with a whole virus par...
Despite the availability of annually formulated vaccines, influenza virus infection remains a worldw...
<p>Virus infection status was determined by PCR for SIV<i>gag</i> proviral DNA and virus isolation (...
Fulltext embargoed for: 6 months post date of publicationYearly vaccination with the trivalent inact...
<p>Virus infection status was determined by PCR for SIV<i>gag</i> proviral DNA and virus isolation (...
<p>(<b>A</b>) Three groups of macaques (N = 8) were immunized 4 times (V1 to V4) with SIVmac239 deri...
<p>Virus infection status was determined by PCR for SIV<i>gag</i> proviral DNA and virus isolation (...
We made an H1N1 vaccine candidate from a virus library consisting of 144 ( = 16 HA69 NA) non-pathog...
(A) Macaques (n = 3 per group) were infected with A/Yokohama/91/2007 (H1N1) and 56 days later vaccin...
(A) Volcano plots of 17 humoral immune parameters following either one (SV or WPV) or two doses (SV⇢...
(A) Plasma collected at each time point was assessed for HI against vaccine-matched H1N1, H3N2 and I...
(A) Macaques (n = 8 per group) were vaccinated with quadrivalent WPV or SV formulations. A second do...
(A) Plasma from animals vaccinated with monovalent A/Singapore/GP1908/2015 (H1N1) WPV or SV (day 28)...
Macaques (n = 9 per group) were vaccinated with monovalent A/Singapore/GP1908/2015 (H1N1) WPV or SV ...
<p>Cynomolgus macaques (n = 8) received 3 immunizations with the LT-MA DNA vaccine at 0, 6, and 12 w...
<p>Cynomolgus macaques were subcutaneously immunized twice (in weeks 0 and 2) with a whole virus par...
Despite the availability of annually formulated vaccines, influenza virus infection remains a worldw...
<p>Virus infection status was determined by PCR for SIV<i>gag</i> proviral DNA and virus isolation (...
Fulltext embargoed for: 6 months post date of publicationYearly vaccination with the trivalent inact...
<p>Virus infection status was determined by PCR for SIV<i>gag</i> proviral DNA and virus isolation (...
<p>(<b>A</b>) Three groups of macaques (N = 8) were immunized 4 times (V1 to V4) with SIVmac239 deri...
<p>Virus infection status was determined by PCR for SIV<i>gag</i> proviral DNA and virus isolation (...
We made an H1N1 vaccine candidate from a virus library consisting of 144 ( = 16 HA69 NA) non-pathog...